Literature DB >> 15758854

Is the use of oral creatine supplementation safe?

E Bizzarini1, L De Angelis.   

Abstract

This review focuses on the potential side effects caused by oral creatine supplementation on gastrointestinal, cardiovascular, musculoskeletal, renal and liver functions. No strong evidence linking creatine supplementation to deterioration of these functions has been found. In fact, most reports on side effects, such as muscle cramping, gastrointestinal symptoms, changes in renal and hepatic laboratory values, remain anecdotal because the case studies do not represent well-controlled trials, so no causal relationship between creatine supplementation and these side-effects has yet been established. The only documented side effect is an increase in body mass. Furthermore, a possibly unexpected outcome related to creatine monohydrate ingestion is the amount of contaminants present that may be generated during the industrial production. Recently, controlled studies made to integrate the existing knowledge based on anecdotal reports on the side effects of creatine have indicated that, in healthy subjects, oral supplementation with creatine, even with long-term dosage, may be considered an effective and safe ergogenic aid. However, athletes should be educated as to proper dosing or to take creatine under medical supervision.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15758854

Source DB:  PubMed          Journal:  J Sports Med Phys Fitness        ISSN: 0022-4707            Impact factor:   1.637


  10 in total

1.  To Supplement or Not.

Authors:  Margaret E Gibson; Jon Schultz; Drew Glover
Journal:  Mo Med       Date:  2016 Jul-Aug

2.  Creatine monohydrate supplement induced interstitial nephritis.

Authors:  Mohammadreza Ardalan; Zahra Samadifar; Amir Vahedi
Journal:  J Nephropathol       Date:  2012-07-01

3.  Comparison of antihyperglycemic effects of creatine and glibenclamide in type II diabetic patients.

Authors:  Boris Ročić; Ariana Znaor; Petra Ročić; David Weber; Marijana Vučić Lovrenčić
Journal:  Wien Med Wochenschr       Date:  2011-07-29

4.  Dietary supplement adverse events: report of a one-year poison center surveillance project.

Authors:  Christine Haller; Tom Kearney; Stephen Bent; Richard Ko; Neal Benowitz; Kent Olson
Journal:  J Med Toxicol       Date:  2008-06

5.  Effects of high-dose creatine supplementation on kidney and liver responses in sedentary and exercised rats.

Authors:  Renato A Souza; Humberto Miranda; Murilo Xavier; Rodrigo A Lazo-Osorio; Hélio A Gouvea; José C Cogo; Rodolfo P Vieira; Wellington Ribeiro
Journal:  J Sports Sci Med       Date:  2009-12-01       Impact factor: 2.988

6.  Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.

Authors:  Tracy L Hellem; Young-Hoon Sung; Xian-Feng Shi; Marjorie A Pett; Gwen Latendresse; Jubel Morgan; Rebekah S Huber; Danielle Kuykendall; Kelly J Lundberg; Perry F Renshaw
Journal:  J Dual Diagn       Date:  2015

7.  Creatine supplementation with specific view to exercise/sports performance: an update.

Authors:  Robert Cooper; Fernando Naclerio; Judith Allgrove; Alfonso Jimenez
Journal:  J Int Soc Sports Nutr       Date:  2012-07-20       Impact factor: 5.150

8.  The effects of the recommended dose of creatine monohydrate on kidney function.

Authors:  Basturk Taner; Ozagari Aysim; Unsal Abdulkadir
Journal:  NDT Plus       Date:  2010-10-11

Review 9.  Creatine supplementation during pregnancy: summary of experimental studies suggesting a treatment to improve fetal and neonatal morbidity and reduce mortality in high-risk human pregnancy.

Authors:  Hayley Dickinson; Stacey Ellery; Zoe Ireland; Domenic LaRosa; Rodney Snow; David W Walker
Journal:  BMC Pregnancy Childbirth       Date:  2014-04-27       Impact factor: 3.007

Review 10.  Risk of Adverse Outcomes in Females Taking Oral Creatine Monohydrate: A Systematic Review and Meta-Analysis.

Authors:  Deborah L de Guingand; Kirsten R Palmer; Rodney J Snow; Miranda L Davies-Tuck; Stacey J Ellery
Journal:  Nutrients       Date:  2020-06-15       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.